SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-025788
Filing Date
2021-11-09
Accepted
2021-11-09 08:29:00
Documents
16
Period of Report
2021-11-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20211108_8k.htm   iXBRL 8-K 30360
2 EXHIBIT 99.1 ex_304496.htm EX-99.1 17473
3 EXHIBIT 99.2 ex_304555.htm EX-99.2 19267
8 logo.jpg GRAPHIC 3311
  Complete submission text file 0001437749-21-025788.txt   218327

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arav-20211109.xsd EX-101.SCH 3593
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20211109_def.xml EX-101.DEF 11807
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20211109_lab.xml EX-101.LAB 15858
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20211109_pre.xml EX-101.PRE 12022
9 EXTRACTED XBRL INSTANCE DOCUMENT arav20211108_8k_htm.xml XML 2653
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 211390007
SIC: 2834 Pharmaceutical Preparations